1361 related articles for article (PubMed ID: 33201896)
1. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
Izcovich A; Ragusa MA; Tortosa F; Lavena Marzio MA; Agnoletti C; Bengolea A; Ceirano A; Espinosa F; Saavedra E; Sanguine V; Tassara A; Cid C; Catalano HN; Agarwal A; Foroutan F; Rada G
PLoS One; 2020; 15(11):e0241955. PubMed ID: 33201896
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
4. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
5. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
6. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
7. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
Borges do Nascimento IJ; von Groote TC; O'Mathúna DP; Abdulazeem HM; Henderson C; Jayarajah U; Weerasekara I; Poklepovic Pericic T; Klapproth HEG; Puljak L; Cacic N; Zakarija-Grkovic I; Guimarães SMM; Atallah AN; Bragazzi NL; Marcolino MS; Marusic A; Jeroncic A;
PLoS One; 2020; 15(9):e0239235. PubMed ID: 32941548
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
9. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
10. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
13. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
16. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
[TBL] [Abstract][Full Text] [Related]
17. Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Lamontagne F; Han MA; Agarwal A; Agoritsas T; Azab M; Bravo G; Chu DK; Couban R; Devji T; Escamilla Z; Foroutan F; Gao Y; Ge L; Ghadimi M; Heels-Ansdell D; Honarmand K; Hou L; Ibrahim Q; Khamis A; Lam B; Mansilla C; Loeb M; Miroshnychenko A; Marcucci M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Pardo-Hernandez H; Rada G; Rizwan Y; Saadat P; Switzer C; Thabane L; Tomlinson G; Vandvik PO; Vernooij RW; Viteri-García A; Wang Y; Yao L; Zhao Y; Guyatt GH; Brignardello-Petersen R
BMJ; 2020 Jul; 370():m2980. PubMed ID: 32732190
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
Zheng Z; Peng F; Xu B; Zhao J; Liu H; Peng J; Li Q; Jiang C; Zhou Y; Liu S; Ye C; Zhang P; Xing Y; Guo H; Tang W
J Infect; 2020 Aug; 81(2):e16-e25. PubMed ID: 32335169
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].
Zhang J; Li J; Su L; Yang J; Jiang X; Jiang N; Lei Y; He L; Lu Q; Shen S; Chen F; Peng Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):407-411. PubMed ID: 32527342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
